We are happy to present more videos for the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual...
Clinical Trials
Clinical Trials
If you have been NEWLY DIAGNOSED START HERE
Video Library
Cancer Journey:
Cancer Type:
Disease Learning:
We are happy to present more videos for the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual...
Cancer Journey:
Cancer Type:
Disease Learning:
We are happy to present more videos for the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual...
Cancer Journey:
Cancer Type:
Disease Learning:
We are happy to present more videos for the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual...
Cancer Journey:
Cancer Type:
Disease Learning:
We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual discussion with...
Cancer Journey:
Cancer Type:
- 1 of 4
- View More
Articles
Download slides from LIVE WEBCAST of November 18, 2017 in partnership with Georgetown University Hospital, GRACE presents: 2017 Advances in Immunotherapy: What Lung Cancer Patients Need to Know
Cancer Journey:
Cancer Type:
Disease Learning:
Many physicians worship evidence-based medicine, which is generally a very good practice that ensures that medical practice isn’t dictated by our...
Cancer Journey:
Cancer Type:
Disease Learning:
Dr. Jack West reviews the Lung Cancer Master Protocol for second line treatment of patients with advanced squamous NSCLC, an "umbrella protocol" in which all patients undergo molecular testing and have treatment assigned by the results.
Cancer Journey:
Cancer Type:
Dr. Ross Camidge talks about a clinical trial that will test to see if the drug tesevatinib will work to kill cancer that has progressed in the brains of EGFR-mutant lung cancer patients. The trial is scheduled to begin in late 2015 or early 2016.
Cancer Journey:
Cancer Type:
Disease Learning:
Dr. Jack West reviews the concept of epigenetics, epigenetic priming, and whether oral azacytidine can improve outcomes in patients who receive immunotherapy for advanced lung cancer.
Cancer Journey:
Cancer Type:
Disease Learning:
- 1 of 19
- View More
Community Forum
No Result Found